Schedule 13D ownership disclosure

PHASEBIO PHARMACEUTICALS INC

Security class unavailable · CUSIP: 717224109

Event date: 2018-10-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,004,554
Percent of class
12.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-064340
Form type
SC 13D
Filer
ASTRAZENECA PLC
CIK
CIK 901832
Filed
Oct 29, 2018
Reporting period
Oct 17, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub